MedPage Today
(MedPage Today) -- Variable weight-loss and cardiovascular benefits were seen with GLP-1 drugs in a systematic review and network meta-analysis, but effects on quality of life were less clear. Across 262 randomized studies published through November...
Taking you to the source… click here if nothing happens